๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wenzhou
Clinical trial register · China

Clinical Trials in Wenzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital of Wenzhou Medical University32 First Affiliated Hospital of Wenzhou Medical University27 The Eye Hospital of Wenzhou Medical University9 Janssen Research & Development, LLC5 Wenzhou Medical University5
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Wenzhou

184 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
The EEG Study Under Remimazolam Anesthesia in Children
NCT06698705Electroencephalography, Remimazolam, Child Neglect
Second Affiliated Hospital of Wenzhou Medical University
Observational
60
Wenzhou
2024-11-22
Recruiting
Study on Aging and Cognitive Impairment in China
NCT06679296Cognitive Dysfunction, Aging
First Affiliated Hospital of Wenzhou Medical University
Observational
20,000
Wenzhou
2024-11-20
Not yet open
Assessing Diabetic Foot Ulcer Microcirculation With High-frequency Contrast Enhanced Ultrasound
NCT06309082Diabetes Mellitus
First Affiliated Hospital of Wenzhou Medical University
Observational
100
Wenzhou
2024-11
Recruiting
Correlation Studies on Human Body Composition Based on Bioequivalence or Pharmacokinetic Trials
NCT07611929Healhty
Second Affiliated Hospital of Wenzhou Medical University
Observational
3,000
Wenzhou
2024-10-05
Active, closed
Comparison of the Effect of Capsular Bend on the Rotational Stability Between Two Toric Intraocular Lenses
NCT06707740Cataract
Wenzhou Medical University
Observational
68
Wenzhou
2024-10-01
Recruiting
Zhejiang Adolescent Spine and Vision Health Cohort: A Longitudinal Database Analysis
NCT06992622Scoliosis Idiopathic, Myopia, Vision Disorders
Second Affiliated Hospital of Wenzhou Medical University
Observational
73,000
Wenzhou
2024-09-30
Recruiting
Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)
NCT06726421Renal Cell Carcinoma (Kidney Cancer), Kidney Cancer Metastatic, Renal Cell Carcinoma Metastatic
Sun Yat-sen University
Phase 3
252
Fuzhou, Guangzhou, Wuhan, Changchun, Chengdu, Wenzhou, Beijing, Shanghai
2024-09-18
Recruiting
The EEG Study Under Sevoflurane Anesthesia in Children
NCT06580028Electroencephalography, Sevoflurane, Child Neglect
Second Affiliated Hospital of Wenzhou Medical University
Observational
280
Wenzhou
2024-09-04
Recruiting
Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch Viscoelastography
NCT06316869Portal Hypertension, Cirrhosis
First Affiliated Hospital of Wenzhou Medical University
Observational
216
Wenzhou
2024-09-02
Not yet open
Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer
NCT06580665Non-small Cell Lung Cancer
Shanghai Chest Hospital
Not applicable
134
Wuhan, Nanchang, Shanghai, รœrรผmqi, Wenzhou
2024-09-01
Recruiting
A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer
NCT07122414Non-muscle Invasive Bladder Cancer (NMIBC)
Suzhou Forlong Biotechnology Co., Ltd
Phase 1/2
80
Beijing, Fuzhou, Wenzhou, Changsha, Nanjing, Suzhou, Qingdao, Chengdu
2024-08-16
Recruiting
Idiopathic Scoliosis New Onset and Melatonin Phase Delay in Children
NCT06502613Scoliosis Idiopathic, Circadian Rhythm, Melatonin
Second Affiliated Hospital of Wenzhou Medical University
Observational
956
Wenzhou
2024-08-01
By invitation
MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis
NCT06434376Colorectal Cancer
Second Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1
10
Wenzhou
2024-07-01
Recruiting
Intraventricular Administration of Intracranial Infections Caused by ๏ผˆCarbapenem-resistant Gram-negative Bacilli๏ผ‰CRGNB
NCT06595979Intracranial Infections
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
222
Hangzhou, Ningbo, Wenzhou
2024-06-25
Recruiting
Anesthesia and Perioperative Neurocognitive Disorders in the Elderly Patients Undergoing Hip Fracture Surgery Platform Trial (ANDES Platform Trial)
NCT06452147Anesthesia, Hip Fractures, Dementia, Cognitive Impairment
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
1,860
Wenzhou
2024-06-19
Not yet open
The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases
NCT06420154Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Systemic Sclerosis, Inflammatory Myopathy
First Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1
9
Wenzhou
2024-05-27
Recruiting
AMT-116 in Patients with Solid Tumors
NCT06782334Advanced Solid Tumors
Multitude Therapeutics Inc.
Phase 1/2
144
Fuzhou, Dongguan, Guangzhou, Nanning, Changsha, Hangzhou, Wenzhou
2024-05-07
Recruiting
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
NCT06384352Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1
500
Beijing, Hangzhou, Wenzhou, Chengdu, Guangzhou
2024-05-01
Active, closed
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guรฉrin (BCG)
NCT06211764Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC
Phase 3
272
Beijing, Cheng Du Shi, Chongqing, Guangzhou, Shenyang, Tianjin, Wenzhou, Wuhan
2024-04-09
Recruiting
Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms
NCT06767813Pancreatic Neoplasms
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
80
Zhengzhou, Nanjing, Suzhou, Shanghai, Wenzhou
2024-03-19
Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
NCT05835310Systemic Lupus Erythematosus
AstraZeneca
Phase 3
100
Beijing, Changchun, Changsha, Dongguan, Nanjing, Shanghai, Suzhou, Wenzhou
2024-03-14
Recruiting
Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
NCT05986864Neovascular Age-related Macular Degeneration
Skyline Therapeutics (US) Inc.
Phase 1/2
68
Hefei, Hangzhou, Wenzhou, Beijing
2024-02-23
Recruiting
Left Roof Linear, Mitral Isthmus Linear and Left Anterior Septal Linear Ablation for Non-paroxysmal AF: PROMISED Trial.
NCT06249347Atrial Fibrillation, Atrial Fibrillation, Persistent
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
166
Wenzhou
2024-01-28
Not yet open
A Novel Approach Integrating Magnetic Resonance Imaging (MRI) Data and Artificial Intelligence for Predicting the Success Rate of Vaginal Delivery in Pregnant Women
NCT06044129Vaginal Delivery
Second Affiliated Hospital of Wenzhou Medical University
Observational
200
Wenzhou
2024-01-01
Recruiting
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease๏ผˆOCEAN PROJECT๏ผ‰
NCT06368882Nonalcoholic Fatty Liver Disease, Chronic Hepatitis b
First Affiliated Hospital of Wenzhou Medical University
Phase 4
1,500
Ningbo, Ruiโ€™an, Wenzhou, Yueqing
2024-01-01
Recruiting
Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC
NCT06341907Epithelial Ovarian Cancer
Second Affiliated Hospital of Wenzhou Medical University
Phase 2/3
10
Wenzhou
2024-01-01
Recruiting
Elderly Patients Undergoing Surgery During Perioperative Period
NCT07314762Postoperative Complications, Elderly, Postoperative Delirium (POD), Risk Prediction Model
Second Affiliated Hospital of Wenzhou Medical University
Observational
1,200
Wenzhou
2023-12-30
Recruiting
A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma
NCT06235229Multiple Myeloma
Gracell Biotechnologies (Shanghai) Co., Ltd.
Phase 1/2
110
Beijing, Hangzhou, Jinan, Shanghai, Shenyang, Wenzhou, Wuhan, Xi'an
2023-12-26
Active, closed
Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study
NCT05991323Prurigo Nodularis
Sanofi
Observational
100
Guangzhou, Xi'an, Jinan, Hangzhou, Wenzhou, Beijing, Shanghai, Shenzhen
2023-12-12
By invitation
Study on the Sociopsychoemotional Mechanism of Dysfunction in Patients With Acute and Chronic Low Back Pain
NCT06684665Low Back Pain
Second Affiliated Hospital of Wenzhou Medical University
Observational
1,000
Wenzhou
2023-11-27
Recruiting
Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer
NCT05737303Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III, Fallopian Tube Carcinoma Stage IV
Women's Hospital School Of Medicine Zhejiang University
Phase 3
538
Guangzhou, Ji'nan, Hangzhou, Ningbo, Wenzhou
2023-11-27
Recruiting
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
NCT06095089Prostatic Neoplasms
Janssen Research & Development, LLC
Phase 1
355
Wenzhou
2023-11-01
Recruiting
Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized๏ผŒOpen-label Clinical Trial.
NCT06079788Nephrotic Syndrome in Children
Mao Jianhua
Phase 3
140
Wuhan, Nanjing, Kunming, Hangzhou, Ningbo, Wenzhou, Beijing, Shanghai
2023-11-01
Recruiting
Effect of FPCA on Incidence of Emergency Delirium in Children After Surgery
NCT06092671Postoperative Complications, Child, Family, Emergence Delirium
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
444
Wenzhou
2023-10-24
Recruiting
Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study
NCT06114784Severe Pneumonia
First Affiliated Hospital of Zhejiang University
Observational
2,000
Hangzhou, Huzhou, Jiaxing, Lanxi, Lishui, Pinghu, Taizhou, Wenzhou
2023-09-25
Recruiting
Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection
NCT06052033HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions, HPV Infection, Photodynamic Therapy
First Affiliated Hospital of Wenzhou Medical University
Not applicable
40
Wenzhou
2023-09-11
Active, closed
A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis
NCT06474416Herpes Simplex Virus Type I Stromal Keratitis
Shanghai BDgene Co., Ltd.
Phase 1
16
Shanghai, Hangzhou, Wenzhou
2023-09-04
Recruiting
A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children
NCT06151587Myopia
Qilu Pharmaceutical Co., Ltd.
Phase 3
735
Wenzhou
2023-08-20
Active, closed
S.T.O.P.ยฎ Technology Contact Lenses Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children
NCT05243836Myopia
nthalmic Pty Ltd
Not applicable
441
Wenzhou, Tianjin, Shanghai
2023-08-04
Recruiting
Early Diagnosis and Prediction of Maternal and Neonatal Diseases:
NCT06791343Pregnancy-Related and Neonatal Disorders
The Eye Hospital of Wenzhou Medical University
Observational
1,000,000
Guangzhou, Wenzhou
2023-08-01
Recruiting
AI-Agent for Automated Diagnosis and Predicting Using EHR and Multimodal Data
NCT06791499AI Agent
The Eye Hospital of Wenzhou Medical University
Observational
2,000,000
Guangzhou, Chengdu, Wenzhou
2023-07-01
Recruiting
AI-Driven Genotype Prediction Using EHR and Multimodal Data
NCT06791421Genotype
The Eye Hospital of Wenzhou Medical University
Observational
100,000
Guangzhou, Wenzhou
2023-07-01
Recruiting
The Effect of Erythropoietin on Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome
NCT05857891Acute Respiratory Distress Syndrome
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
40
Wenzhou
2023-05-20
Recruiting
Wenzhou Gestational Diabetes Cohort
NCT05794152Gestational Diabetes Mellitus, Intrauterine Hyperglycemia, Birth Outcome, Adverse, Nutrition, Healthy
Westlake University
Not applicable
300
Wenzhou
2023-03-21
Recruiting
AI-Driven Prediction of Biological Age With EHR
NCT06791486Biological Age
The Eye Hospital of Wenzhou Medical University
Observational
1,000,000
Guangzhou, Wenzhou
2023-03-01
Recruiting
AI-Driven Prediction of Hospital-Acquired Infections With EHR
NCT06791382Hospital-acquired Infections
The Eye Hospital of Wenzhou Medical University
Observational
1,000,000
Wenzhou
2023-02-01
Active, closed
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
NCT05538130Melanoma, Glioma, Thyroid Cancer, Non-Small Cell Lung Cancer
Pfizer
Phase 1
148
Hangzhou, Wenzhou
2022-11-30
Active, closed
LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB
NCT05572957Non-ischemic Cardiomyopathy, Heart Failure, Left Bundle-Branch Block
The First Affiliated Hospital with Nanjing Medical University
Not applicable
50
Beijing, Fuzhou, Nanjing, Dalian, Chengdu, Wenzhou
2022-10-14
Active, closed
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis
NCT05503264NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis
Hoffmann-La Roche
Phase 3
122
Beijing, Chengdu, Fuzhou, Jining, Shanghai, Wenzhou
2022-09-27
Recruiting
Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
NCT05446467Head and Neck Squamous Cell Carcinoma
Zhejiang Provincial People's Hospital
Phase 2
80
Qingdao, Hangzhou, Ningbo, Tianjin, Wenzhou
2022-09-01
Recruiting
Dual-port Trans-subclavian Thyroid Endoscopic Surgery
NCT06398795Thyroid Neoplasms, Endoscopic Surgery
First Affiliated Hospital of Wenzhou Medical University
Not applicable
300
Wenzhou
2022-09-01
Active, closed
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
NCT05263934Eosinophilic Granulomatosis With Polyangiitis
GlaxoSmithKline
Phase 3
163
Beijing, Guangzhou, Hefei, Nanjing, Qingdao, Shanghai, Shenzhen, Wenzhou
2022-07-14
Recruiting
Human BCMA Targeted T Cells Injection๏ผˆBCMA CAR-T๏ผ‰for Subjects With R/R MM
NCT05594797Multiple Myeloma
Hrain Biotechnology Co., Ltd.
Phase 2
100
Shanghai, Wenzhou
2022-07-12
Active, closed
A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium
NCT05456425Pterygium
Cloudbreak Therapeutics, LLC
Phase 3
660
Beijing, Chengdu, Haikou, Hengyang, Kunming, Nanchang, Qingdao, Wenzhou
2022-06-30
Active, closed
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT04975997Multiple Myeloma
Celgene
Phase 3
939
Changsha, Nanchang, Xi'an, Shanghai, Taiyuan, Wenzhou, Beijing, Changchun
2022-06-23
Recruiting
A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery
NCT05242419Injection, Non-cardiac Surgery, Delirium in Old Age, Post Operative Delirium
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
40
Wenzhou
2022-06-10
Recruiting
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
NCT05356104Cerebral Small Vessel Disease
Chinese University of Hong Kong
Phase 2
110
Wenzhou
2022-05-25
By invitation
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab
NCT05303532Cancer
AstraZeneca
Phase 3
214
Beijing, Changsha, Hangzhou, Nanjing, Shanghai, Shenyang, Wenzhou, Xi'an
2022-04-19
Active, closed
Olorofim Aspergillus Infection Study
NCT05101187Invasive Aspergillosis
F2G Biotech GmbH
Phase 3
225
Bengbu, Wuhan, Nanchang, Jinan, Shanghai, Xiaobailou, Wenzhou, Beijing
2022-03-31
Active, closed
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
NCT05317416Multiple Myeloma
Pfizer
Phase 3
854
Guangzhou, Tianjin, Wenzhou
2022-03-25
Recruiting
A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
NCT05851014Breast Cancer
Genor Biopharma Co., Ltd.
Phase 3
350
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Wenzhou, Xiamen, Foshan
2022-01-14
Active, closed
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)
NCT05156281Relapsing Multiple Sclerosis
Novartis Pharmaceuticals
Phase 3
1,007
Wuhan, Nanjing, Yinchuan, Taiyuan, Hangzhou, Wenzhou, Beijing, Shanghai
2021-12-13
Recruiting
A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer
NCT06234137Breast Neoplasm Female
Wang Ouchen
Not applicable
154
Wenzhou
2021-11-27
Recruiting
Immune Score Based Radiomics in Nasopharyngeal Carcinoma
NCT05126160Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Observational
494
Wuhan, Ningbo, Wenzhou, Hangzhou
2021-11-05
Active, closed
Anlotinib Capsules in the Treatment for IPF/PF-ILDs
NCT05828953Interstitial Lung Diseases
First Affiliated Hospital of Wenzhou Medical University
Phase 2
30
Wenzhou
2021-09-28
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
BeOne Medicines
Phase 1/2
645
Beijing, Guangzhou, Zhengzhou, Yichang, Shanghai, Tianjin, Wenzhou
2021-09-13
By invitation
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
NCT04976322Systemic Lupus Erythematosus
UCB Biopharma SRL
Phase 3
760
Beijing, Changchun, Guangzhou, Guilin, Shanghai, Suzhou, Tianjin, Wenzhou
2021-07-27
Active, closed
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer
NCT04898634Prostatic Neoplasms
Janssen Research & Development, LLC
Phase 1
216
Beijing, Chongqing, Guangzhou, Wenzhou
2021-07-13
Recruiting
Gastric Cancer Marker Detection and Its Kit Development
NCT05010863Gastric Cancer
Second Affiliated Hospital of Wenzhou Medical University
Observational
530
Wenzhou
2021-01-01
Recruiting
Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events
NCT04559243Non-valvular Atrial Fibrillation, Embolic Stroke
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
579
Jinan, Shanghai, Mianyang, Wenzhou
2020-11-12
Active, closed
A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)
NCT04512235AL Amyloidosis
Alexion Pharmaceuticals, Inc.
Phase 3
281
Beijing, Guangzhou, Hangzhou, Shanghai, Suzhou, Wenzhou, Wuhan
2020-11-03
Active, closed
Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02)
NCT04515615Gastric Cancer Stage III
Yu jiren
Phase 2
52
Hangzhou, Lishui, Taizhou, Wenzhou
2020-09-09
Active, closed
A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)
NCT04504825AL Amyloidosis
Alexion Pharmaceuticals, Inc.
Phase 3
125
Beijing, Guangzhou, Hangzhou, Wenzhou, Wuhan
2020-08-25
Recruiting
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT04221542Prostate Cancer
Amgen
Phase 1
479
Beijing, Guangzhou, Nanchang, Shanghai, Hangzhou, Nanjing, Wenzhou
2020-03-04
Recruiting
Basic and Clinical Research of Pregnancy-Induced Hypertension
NCT07464379Pregnancy-induced Hypertension
Second Affiliated Hospital of Wenzhou Medical University
Observational
100
Wenzhou
2020-01-01
Recruiting
Post-market Follow Up Study on Paragon CRTยฎ 100 (Paflufocon D)
NCT04187599Myopia
CooperVision International Limited (CVIL)
Not applicable
250
Shanghai, Tianjin, Wenzhou
2019-08-29
Recruiting
Construction of a Multi-center Clinical Research Collaboration Network for Children with Congenital Heart Disease in China
NCT06885307Congenital Heart Disease (CHD)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
35,000
Wuhan, Xining, Shanghai, Kunming, Wenzhou, Jinan
2019-06-01
Active, closed
Idiopathic Scoliosis Progression and Sleep-disordered Breathing in Children
NCT03858244Scoliosis Idiopathic, Sleep Disordered Breathing, Obstructive Sleep Apnea
Second Affiliated Hospital of Wenzhou Medical University
Observational
405
Wenzhou
2019-02-18
By invitation
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001Sepsis, Sepsis and Septic Shock, Infection
Second Affiliated Hospital of Wenzhou Medical University
Observational
100
Wenzhou
2019-01-01
Recruiting
Safety and Efficacy Study of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation
NCT03059043Myopia
Wenzhou Medical University
Not applicable
60
Guangzhou, Changsha, Wenzhou, Beijing, Shanghai
2018-11-16
Active, closed
International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer
NCT03386734Cervical Cancer
Centre Hospitalier Universitaire de Besancon
Not applicable
989
Hangzhou, Wenzhou
2018-05-03
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
Pfizer
Phase 1
453
Guangzhou, Changsha, Nanjing, Chengdu, Wenzhou
2018-04-17
Recruiting
Accuracy of Corneal Astigmatism in Different Region Modes
NCT03299530Astigmatism, Cornea
Wenzhou Medical University
Observational
70
Wenzhou
2017-10-10
Recruiting
The K-Map Study, Global Prevalence of KC
NCT03115710Keratoconus
University Hospital, Geneva
Observational
20,000
Wenzhou
2015-12-28
Rows per page Showing 101–184 of 184
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/wenzhou?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 184 of those studies with a site in Wenzhou.

How many clinical trials are recruiting in Wenzhou?

110 of the 184 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 37 have not yet opened recruitment, 30 are active but closed to new participants, and 7 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.